首页> 外文期刊>The Prostate >Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.
【24h】

Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.

机译:使用癌症进展的分子标记物区分前列腺导管内癌(IDC-P),高度不典型增生(PIN)和浸润性前列​​腺腺癌。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Prostate ducts and acini whose lumens are filled with malignant cells represent a well-recognized histological pattern recently termed intraductal carcinoma of the prostate (IDC-P). These tumors are often associated with rapid disease progression, and most recur after radical surgery. Controversy exists as to whether IDC-P should be recognized as a separate entity, an extension of high-grade dysplasia (PIN) or invasive carcinoma as described by the Gleason grading system. This study investigates the use of molecular markers in defining the position of IDC-P in the evolutionary hierarchy of prostate cancer progression. METHODS: IDC-P, high-grade dysplasia, and invasive cancers from a cohort of 20 selected radical prostatectomy specimens were screened for loss of heterozygosity (LOH), using 12 polymorphic microsatellite markers frequently lost in prostate cancer. RESULTS: LOH was absent in Gleason grade 3 cancer, infrequent in high-grade dysplasia (9%) and Gleason grade 4 cancer (29%), but common in IDC-P (60%). In IDC-P, and to a lesser extent Gleason grade 4 cancers, multiple sites of allelic loss in individual cases were usual. CONCLUSIONS: Allelic instability provides further evidence that IDC-P is not a simple extension of dysplasia, nor does it represent invasion of Gleason grade 3 cancers into the ductal/acinar system. IDC-P and Gleason grade 4 cancer represent late but possibly separate events in prostate cancer evolution. Copyright 2000 Wiley-Liss, Inc.
机译:背景:前列腺管和腺泡的腔内充满了恶性细胞,代表了一种公认的组织学模式,最近被称为前列腺导管内癌(IDC-P)。这些肿瘤通常与疾病的快速发展有关,大多数在根治性手术后复发。关于是否应将IDC-P识别为一个单独的实体,高度不典型增生(PIN)的扩展或Gleason分级系统描述的浸润性癌,存在争议。这项研究调查了分子标记物在定义IDC-P在前列腺癌进展的进化层次中的位置时的用途。方法:使用12种在前列腺癌中经常丢失的多态性微卫星标记,从20个选定的前列腺癌根治术标本队列中筛选IDC-P,高度不典型增生和浸润性癌的杂合性缺失(LOH)。结果:格里森3级癌症不存在LOH,高度不典型增生(9%)和格里森4级癌症(29%)很少见,但IDC-P常见(60%)。在IDC-P和格里森4级癌症(程度较小)中,个别病例中通常存在多个等位基因缺失位点。结论:等位基因的不稳定性提供了进一步的证据,表明IDC-P不是发育异常的简单延伸,也不代表Gleason 3级癌症侵入导管/腺泡系统。 IDC-P和格里森4级癌症代表了前列腺癌进化中的晚期事件,但可能是分开的事件。版权所有2000 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号